Caroline Dubroca
280 Rue De L'Hers
Escalquens, 31750, France
Escalquens, 31750, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD.
Journal: European journal of pharmacology
Published: April 18, 2025
Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats.
Journal: Dose-response : a publication of International Hormesis Society
Published: February 17, 2022
Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters.
Journal: Metabolism: clinical and experimental
Published: October 16, 2020
Liraglutide shows superior cardiometabolic benefits than lorcaserin in a novel free choice diet-induced obese rat model.
Journal: European journal of pharmacology
Published: April 05, 2020
Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity.
Journal: Biochemistry and biophysics reports
Published: September 21, 2018
Cardioprotective Angiotensin-(1-7) Peptide Acts as a Natural-Biased Ligand at the Angiotensin II Type 1 Receptor.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: July 05, 2016
Ephrin-B1 is a novel specific component of the lateral membrane of the cardiomyocyte and is essential for the stability of cardiac tissue architecture cohesion.
Journal: Circulation research
Published: February 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026